Meningococcal Disease
📧 Sign up to get email alerts when something new happens for Meningococcal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-26Clinical Trial Results: A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Infants [Phase 2]
Phase 2 study assessing safety, tolerability, and immune response of a meningococcal ABCWY vaccine in healthy infants; results posted after …
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study Assessing Colonisation & Immunogenicity After Nasal Inoculation With N. Lactamica and Eradication on Day 4 or 14 [NA]
A study evaluating nasal inoculation with Neisseria lactamica to assess colonization and immunogenicity was terminated. Results were posted …
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants [Phase 3]
Phase 3 safety and immunogenicity study of co-administering GSK Meningococcal Group B Vaccine with a 13-valent pneumococcal vaccine and rout…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa [Phase 3]
Phase 3 trial evaluating MenACYW Conjugate Vaccine co-administered with routine pediatric vaccines in healthy infants and toddlers in India …
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the safety and immunogenicity of an investigational pentavalent meningococcal ABCYW vaccine in pediatric partic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents [Phase 1, Phase 2]
This document notes the completion of a Phase 1/Phase 2 trial of an investigational pentavalent meningococcal ABCYW vaccine in adults and ad…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults [Phase 4]
A Phase 4 clinical trial evaluating MenB-FHbp alone or combined with MenACWY-TT in young adults primed with MenB-4C is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers [Phase 3]
A Phase 3 trial evaluating the immunogenicity and safety of a Meningococcal ACYW Conjugate Vaccine in healthy infants and toddlers has been …
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy [Phase 4]
Phase 4 study evaluating immunogenicity and safety of MenQuadfi as a booster in toddlers aged 12 to 23 months, regardless of prior infancy p…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population [Phase 3]
A Phase 3 trial of the ACYW135 group meningococcal polysaccharide conjugate vaccine (CRM197 vector) in 4- to 6-year-old children has complet…
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Infants [Phase 2]
A Phase 2 trial evaluating the safety, tolerability, and immune response of the Meningococcal Combined ABCWY Vaccine in healthy infants has …
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon [Phase 3]
Phase 3 trial assessing safety and immunogenicity of a single-dose MenACYW Conjugate Vaccine in older adults in Turkey and Lebanon has compl…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age [Phase 3]
Phase 3 trial results evaluating the safety and immunogenicity of the GSK Meningococcal Group B Vaccine when administered concurrently with …
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults [Phase 1, Phase 2]
This clinical trial update reports Phase 1/2 results assessing the safety, effectiveness, and immune response of the Meningococcal ABCWY vac…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South Africa [Phase 3]
A Phase 3 trial evaluating the immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine in healthy adult…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe [Phase 3]
A Phase 3 study evaluated the immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine when co-administered with routine …
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules [Phase 2]
This Phase 2 trial update describes safety and immunogenicity results for the MenABCWY meningococcal vaccine given on two dosing schedules.
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Trial to Describe the Safety, Tolerability, and Immunogenicity of Trumenba When Administered to Immunocompromised Participants ≥10 Years of Age [Phase 4]
Phase 4 trial assessing safety, tolerability, and immunogenicity of Pfizer's meningococcal group B vaccine Trumenba (rLP2086) in immunocompr…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine given with routine pediatric vaccines i…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine [Phase 3]
Phase 3 immunogenicity and safety results for GSK's MenABCWY meningococcal vaccine in healthy adolescents and adults previously primed with …
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as Toddlers [Phase 3]
Phase 3 study of an investigational MenACYW Conjugate Vaccine evaluating 5- and/or 10-year booster doses in children and adolescents who wer…
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 Months [Phase 3]
Phase 3 trial update assessing immunogenicity and safety of a meningococcal ACYW135 polysaccharide conjugate vaccine in infants aged 3 to 5 …
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Immunogenicity and Safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in Volunteers Aged 3-5 Months [Phase 3]
A Phase 3 trial update reports on the immunogenicity and safety of group A and C meningococcal polysaccharide conjugate vaccine in healthy i…
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: A Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of MenABCWY in Healthy Infants [Phase 2]
Phase 2 trial assessing safety, tolerability, and immunogenicity of MenABCWY vaccine in healthy infants was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-18Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of Nimenrix (Registered) in Healthy Infants, Given at 3 and 12 Months of Age [Phase 3]
A Phase 3 trial evaluating safety and immunogenicity of Nimenrix given at 3 and 12 months in healthy infants has completed with results post…